Mast Cells as Effectors in Atherosclerosis

被引:114
|
作者
Bot, Ilze [1 ]
Shi, Guo-Ping [2 ,3 ]
Kovanen, Petri T. [4 ]
机构
[1] Leiden Univ, Div Biopharmaceut, Leiden Acad Ctr Drug Res, NL-2333 CC Leiden, Netherlands
[2] Brigham & Womans Hosp, Dept Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Wihuri Res Inst, SF-00140 Helsinki, Finland
基金
美国国家卫生研究院;
关键词
atherosclerosis; leukocytes; mast cells; TRYPTASE LEVELS; PROMOTE ATHEROSCLEROSIS; PLAQUE DESTABILIZATION; MYOCARDIAL-INFARCTION; CORONARY PLAQUES; SHOULDER REGION; CHYMASE; ACTIVATION; DENSITY; APOPTOSIS;
D O I
10.1161/ATVBAHA.114.303570
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mast cell is a potent immune cell known for its functions in host defense responses and diseases, such as asthma and allergies. In the past years, accumulating evidence established the contribution of the mast cell to cardiovascular diseases as well, in particular, by its effects on atherosclerotic plaque progression and destabilization. Through its release not only of mediators, such as the mast cell-specific proteases chymase and tryptase, but also of growth factors, histamine, and chemokines, activated mast cells can have detrimental effects on its immediate surroundings in the vessel wall. This results in matrix degradation, apoptosis, and enhanced recruitment of inflammatory cells, thereby actively contributing to cardiovascular diseases. In this review, we will discuss the current knowledge on mast cell function in cardiovascular diseases and speculate on potential novel therapeutic strategies to prevent acute cardiovascular syndromes via targeting of mast cells.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 50 条
  • [21] Mast cells promote atherosclerosis by releasing proinflammatory cytokines
    Sun, Jiusong
    Sukhova, Galina K.
    Wolters, Paul J.
    Yang, Min
    Kitamoto, Shiro
    Libby, Peter
    MacFarlane, Lindsey A.
    Clair, Jon Mallen-St
    Shi, Guo-Ping
    NATURE MEDICINE, 2007, 13 (06) : 719 - 724
  • [22] Atherosclerosis: a chronic inflammatory disease mediated by mast cells
    Conti, Pio
    Shaik-Dasthagirisaeb, Yazdami
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (03) : 380 - 386
  • [23] ROLE OF MAST CELLS IN ATHEROSCLEROSIS: A CLASSICAL INFLAMMATORY DISEASE
    Spinas, E.
    Kritas, S. K.
    Saggini, A.
    Mobili, A.
    Caraffa, A.
    Antinolfi, P.
    Pantalone, A.
    Tei, M.
    Speziali, A.
    Saggini, R.
    Conti, P.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (04) : 517 - 521
  • [24] Mast cells promote atherosclerosis by releasing proinflammatory cytokines
    Jiusong Sun
    Galina K Sukhova
    Paul J Wolters
    Min Yang
    Shiro Kitamoto
    Peter Libby
    Lindsey A MacFarlane
    Jon Mallen-St Clair
    Guo-Ping Shi
    Nature Medicine, 2007, 13 : 719 - 724
  • [25] INFLUENCE OF MAST CELLS UPON DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS IN RAT
    DOUGLAS, CR
    OBERTI, C
    TALESNIK, J
    ESCOBAR, E
    PERELMAN, M
    ACTA PHYSIOLOGICA LATINOAMERICANA, 1962, 12 (03) : 271 - &
  • [26] The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review
    Hamideh Kouhpeikar
    Zahra Delbari
    Thozhukat Sathyapalan
    Luis E. Simental-Mendía
    Tannaz Jamialahmadi
    Amirhossein Sahebkar
    Current Atherosclerosis Reports, 2020, 22
  • [27] The role of mast cells in aortic intima in development of human atherosclerosis
    Sommer, H. -J.
    ADVANCES IN HEART DISEASE, 2006, : 635 - 637
  • [28] SUSCEPTIBILITY TO EXPERIMENTAL ATHEROSCLEROSIS - RELATION TO MAST-CELLS AND HEPARIN
    SUE, TK
    JAQUES, LB
    ATHEROSCLEROSIS, 1976, 25 (01) : 137 - 139
  • [29] The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review
    Kouhpeikar, Hamideh
    Delbari, Zahra
    Sathyapalan, Thozhukat
    Simental-Mendia, Luis E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (05)
  • [30] Role of mast cells in atherosclerosis: From fatty streak to rupture
    Kovanen, PT
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 289 - 289